The teams at Arcinova are experienced in the development, validation, application and technology transfer of GC (headspace or direct injection), ion chromatography, LC and UPLC based methodologies.
These activities are supported by a range of LC detector types including UV, DAD, N2 emission, radiochemical, MS (single quadrupole, triple quadrupole and accurate mass), ICP-MS, conductivity, fluorescence and CAD. In the case of GC, FID or TCD detection are available. Chromatographic services can be accessed for discrete projects or as part of integrated Arcinova services.
The identification of drug impurities or their degradation products is an integral part of the drug development process.
Linked to our expertise in chromatographic separation/isolation, on-site high field NMR, accurate mass spectrometry and synthetic capabilities, Arcinova scientists can offer a complete service for the identification and if relevant, chromatographic response factor determination, for impurities and degradation products of concern. This service can be accessed on a stand-alone basis or as part of an integrated CMC service.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationThe annual dinner meeting and innovation celebration will be attended by Masha Kononov, Senior Director Emerging Pharma US.
BioNH's 2019 Annual Dinner Meeting & Innovation CelebrationDates: 7th FebruaryLocation: New Brunswick, NJ
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 16th - 17th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany